ADC Therapeutics ADCT
NYSE ADCT
$1.43 -0.16 (-10.06%)
At close: Oct 23, 2026 · 4:00 PM EDT

ADC Therapeutics (ADCT) Gains from Investment Securities (2020 - 2022)

Updated

Analysis

ADC Therapeutics (ADCT) Gains from Investment Securities (2020 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 ADC Therapeutics 182.24 Mn -763.95 Mn 16.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -4.66 Mn
Jun 30, 2022 14.46 Mn
Mar 31, 2022 15.86 Mn
Dec 31, 2021 18.61 Mn
Sep 30, 2021 -6.94 Mn
Jun 30, 2021 2.05 Mn
Mar 31, 2021 21.17 Mn
Dec 31, 2020 -18,000.00
Sep 30, 2020 33.87 Mn
Jun 30, 2020 -79.26 Mn
API Access

ADC Therapeutics Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=ADCT&period=max&api_key=YOUR_API_KEY